Canada markets closed

Kaleido Biosciences, Inc. (KLDO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 12:33PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.26k
Enterprise Value -16.78M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.00
Price/Book (mrq)0.00
Enterprise Value/Revenue -15.20
Enterprise Value/EBITDA 0.20

Trading Information

Stock Price History

Beta (5Y Monthly) 36.97
52-Week Change 3-50.00%
S&P500 52-Week Change 322.38%
52 Week High 30.2500
52 Week Low 30.0000
50-Day Moving Average 30.0001
200-Day Moving Average 30.0001

Share Statistics

Avg Vol (3 month) 32.91k
Avg Vol (10 day) 31.75k
Shares Outstanding 542.62M
Implied Shares Outstanding 642.62M
Float 842.45M
% Held by Insiders 10.00%
% Held by Institutions 10.03%
Shares Short (Mar 31, 2022) 42.34M
Short Ratio (Mar 31, 2022) 429.34
Short % of Float (Mar 31, 2022) 414.19%
Short % of Shares Outstanding (Mar 31, 2022) 45.49%
Shares Short (prior month Feb 28, 2022) 42.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Dec 31, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,974.39%

Management Effectiveness

Return on Assets (ttm)-99.93%
Return on Equity (ttm)-580.57%

Income Statement

Revenue (ttm)1.1M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)102.50%
Gross Profit (ttm)N/A
EBITDA -85.16M
Net Income Avi to Common (ttm)-90.29M
Diluted EPS (ttm)-2.1600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)38.47M
Total Cash Per Share (mrq)0.9
Total Debt (mrq)21.69M
Total Debt/Equity (mrq)204.52%
Current Ratio (mrq)1.42
Book Value Per Share (mrq)0.25

Cash Flow Statement

Operating Cash Flow (ttm)-77.09M
Levered Free Cash Flow (ttm)-46.02M